NovoCure (NVCR) EBIT Growth (5y) (2019 - 2026)
NovoCure (NVCR) EBIT Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | NovoCure | 2.05 Bn | 1.61 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.99% |
| Mar 31, 2026 | -277.45% |
| Dec 31, 2025 | -39.80% |
| Sep 30, 2025 | -34.48% |
| Jun 30, 2025 | -51.29% |
| Mar 31, 2025 | -62.12% |
| Dec 31, 2024 | -234.02% |
| Sep 30, 2024 | -59.51% |
| Jun 30, 2024 | -97.54% |
| Mar 31, 2024 | -46.67% |
| Dec 31, 2023 | -42.95% |
| Sep 30, 2023 | -61.84% |
| Jun 30, 2023 | -54.64% |
| Mar 31, 2023 | -36.58% |
| Dec 31, 2022 | -57.00% |
| Sep 30, 2022 | -32.98% |
| Jun 30, 2022 | -6.35% |
| Mar 31, 2022 | 42.98% |
| Dec 31, 2021 | -5.53% |
| Sep 30, 2021 | 21.27% |